InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: dr_lowenstein post# 37675

Wednesday, 11/23/2016 12:17:15 PM

Wednesday, November 23, 2016 12:17:15 PM

Post# of 48316
Oncology is a broad term, but as far as eliciting immune response in tumor microenvironments, maybe. We will have to wait to find out, which is why I said if they can prove the aforementioned advantages in clinical trials...
On a side note, dismissing the work of the many scientists at OncoSec with years of big pharma/biotech experience by projecting their work as a one man show driven by PD is a bit unfair, IMO.